As of January 2025 ArriVent BioPharma has a market cap of $0.96 Billion USD. This makes ArriVent BioPharma the world's 5668th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 30th, 2025 the market cap of ArriVent BioPharma was reported to be: